Dogs died in studies of drug that killed man in French trialBMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i1228 (Published 29 February 2016) Cite this as: BMJ 2016;352:i1228
- Nigel Hawkes
Several dogs died in preclinical studies of the experimental drug that killed a human volunteer in a French trial, the French medical safety agency ANSM has confirmed.
But the expert committee the agency established to review the trial’s conduct concluded that these deaths were to be expected in animal testing designed to establish a safe dose for human administration. The protocol for the first in human trial recorded that this “no observed adverse effect level” was determined for mice, rats, dogs, and monkeys.
As part of these studies, ANSM said, “very high doses are administered to determine the maximum tolerated doses, which can …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial